Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch...
System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 25, 2024 4:00pm
New Press Release - Sernova Provides Organizational Update
(TheNewswire)Dr. Philip Toleikis to retire as of April 30, 2024Cost savings from restructuring and strategic transformation anticipated to extend runwayBoard rebuild underwayLONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 – Sernova Corp. (TSX:SVA) (OTC:SEOVF) (FSE/XETRA:PSH)...
read article.
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:58am
Buzz on the Bullboards: A recap of recent activity and stocks in focus
After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 22, 2024 7:00am
New Press Release - Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors
(TheNewswire)Dr. Daniel Mahony to step down to pursue new commitmentLONDON, Ontario; BOSTON, Massachusetts – April 22, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell...
read article.
(3)
•••
LiquidReality
X
View Profile
View Bullboard History
Post by
LiquidReality
on Apr 20, 2024 3:04am
Crickets
This board and all others seem to be dead. Why does Stockhouse suck now? Where did everybody go?
(72)
•••
bbowles
X
View Profile
View Bullboard History
Post by
bbowles
on Apr 10, 2024 12:30pm
AGM
How many of you are going to attend the AGM?
(3)
•••
mongo2
X
View Profile
View Bullboard History
Post by
mongo2
on Apr 09, 2024 9:35pm
why is this dumping?
how low can she go
(26)
•••
Jf4270393
X
View Profile
View Bullboard History
Comment by
Jf4270393
on Apr 09, 2024 12:19pm
RE:RE:Can SVA'S Cell Pouch lead to weight loss??
Perhaps Cell pouch used for weight gain would elevate the share price....
(8)
•••
hoffbag
X
View Profile
View Bullboard History
Post by
hoffbag
on Apr 02, 2024 6:27pm
Good release ?
I wish I was smart and knew why they weren't getting more support from the market. Their immunosuppressive news seems to be a big deal to me.
(115)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Apr 02, 2024 4:06pm
PEOPLE ALWAYS COMPLAIN no matter what.
Many people complain because apparently companies (such as SVA) don't give investors updates. Then when companies issue an update (like today) people get upset because the update didn't
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 7:01am
New Press Release - Sernova Provides Positive Clinical and Platform Portfolio Update
(TheNewswire)Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell PouchFirst treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and normalized HbA1cWith recent...
read article.
(3)
•••
LiquidReality
X
View Profile
View Bullboard History
Comment by
LiquidReality
on Mar 23, 2024 4:04am
RE:RE:Follow the money?
Doesn't matter. What is done is done. More importantly is they are going to need money soon so a financing has got to be coming, and I would most assuredly beleive it will be at a price a lot
...more
(72)
•••
bbowles
X
View Profile
View Bullboard History
Comment by
bbowles
on Mar 22, 2024 12:54pm
RE:Follow the money?
Maybe the question should be where did the 8.5 go? CFO fired for cause and another one being investigated.
(115)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Mar 22, 2024 7:16am
RE:Follow the money?
Good question. You should call or email the company for a reply.
(3)
•••
LiquidReality
X
View Profile
View Bullboard History
Post by
LiquidReality
on Mar 22, 2024 1:52am
Follow the money?
"As at January 31, 2024, we had working capital of $2,886,403 (October 31, 2023 – $11,431,210)." How did they burn $8.5m in 3 months?
(4)
•••
SmallBets
X
View Profile
View Bullboard History
Comment by
SmallBets
on Mar 12, 2024 2:24pm
RE:RE:So the CFO was fired with cause and
ya well, will it be enough to move the needle positively...
(72)
•••
bbowles
X
View Profile
View Bullboard History
Comment by
bbowles
on Mar 11, 2024 12:52pm
RE:So the CFO was fired with cause and
I knew something did not smell right with the board of directors. The change has started.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer